Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "Hyderabad"

275 News Found

LVPEI raises awareness on antimicrobial resistance among medical students
News | June 23, 2023

LVPEI raises awareness on antimicrobial resistance among medical students

Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety


USFDA completes inspection at Dr Reddy's Laboratories' Bollaram API unit
News | June 17, 2023

USFDA completes inspection at Dr Reddy's Laboratories' Bollaram API unit

The inspection closed with zero observations


International cooperation must to advance vaccine development for emerging pathogens: Health Minister Mandaviya
Policy | June 04, 2023

International cooperation must to advance vaccine development for emerging pathogens: Health Minister Mandaviya

The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective


NATCO records FY23 PAT at Rs. 715.3 Cr
News | May 30, 2023

NATCO records FY23 PAT at Rs. 715.3 Cr

The increase in revenue and profits for the year was driven by business growth in the US market and growth in our subsidiaries in Canada & Brazil.


Ministry of Minority Affairs supports development of unani medicine system
Policy | May 26, 2023

Ministry of Minority Affairs supports development of unani medicine system

Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru


Tata 1mg-backed 5C Network launches diagnostics-on-demand platform Prodigi PASS
Healthcare | May 24, 2023

Tata 1mg-backed 5C Network launches diagnostics-on-demand platform Prodigi PASS

5C Network’s groundbreaking platform aims to bring together diagnostic facilities and healthcare aggregators on a single platform to deliver an unparalleled patient experience


Shilpa Medicare Analytical Services Division gets VAI status from USFDA after GMP inspection
Drug Approval | May 23, 2023

Shilpa Medicare Analytical Services Division gets VAI status from USFDA after GMP inspection

This is the second US FDA GMP inspection of this facility within one year


Briefs: Dr. Reddy's Laboratories
News | May 06, 2023

Briefs: Dr. Reddy's Laboratories

USFDA has issued Form 483 with one observation


Syngene International posts Q4 FY2023 consolidated profit at Rs. 178.7 Cr
News | April 27, 2023

Syngene International posts Q4 FY2023 consolidated profit at Rs. 178.7 Cr

The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023